Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer
- 4 July 2015
- journal article
- research article
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 49 (6) , 453-462
Abstract
Objective: The aim of this study was to determine by computed tomography (CT) whether treatment with tumor-draining lymph-node-derived expanded autologous T lymphocytes results in objective responses and/or improved survival in patients with metastatic urinary bladder cancer (UBC) and to record the toxicity of the treatment. Materials and methods: Eighteen patients with metastatic UBC were prospectively selected from two centers. The preoperative staging was T2–T4bN1–2 and/or M0–M1 or MX. Tumor-draining lymph nodes were harvested at intended cystectomy for the extraction of T lymphocytes. This was followed by expansion of the T lymphocytes in a cell culture, and subsequent reinfusion of these autologous tumor-specific T lymphocytes. Responses to therapy were evaluated by CT scans according to Response Evaluation Criteria In Solid Tumors (RECIST) and clinical follow-up, according to the research protocol. Results: Nine out of 18 patients were treated. Treatment was feasible and safe. In two out of nine immunologically treated patients, objective responses were detected in terms of diminished or obliterated nodal metastases. When excluding three patients with disseminated osseous metastases plus one with a T4b tumor left in situ, a success rate of two out of six treated patients was seen. The two responders had survival times of 35 and 11 months, respectively. No toxicity was recorded. Conclusions: Infusion of expanded autologous tumor-specific T lymphocytes is feasible and safe, and objective responses according to RECIST were recorded. One objective responder to immunotherapy displayed notably long overall survival.Keywords
This publication has 32 references indexed in Scilit:
- The present and future burden of urinary bladder cancer in the worldWorld Journal of Urology, 2009
- Hybrid SPECT-CT: An Additional Technique for Sentinel Node Detection of Patients with Invasive Bladder CancerEuropean Urology, 2006
- Radical cystectomy for invasive bladder cancer: long-term results of a standard procedureWorld Journal of Urology, 2006
- Intraoperative Sentinel Node Detection Improves Nodal Staging in Invasive Bladder CancerJournal of Urology, 2006
- LYMPHATIC MAPPING AND DETECTION OF SENTINEL NODES IN PATIENTS WITH BLADDER CANCERJournal of Urology, 2001
- Long-Term Followup of all Patients with Muscle Invasive (Stages T2, T3 and T4) Bladder Carcinoma in a Geographical RegionJournal of Urology, 1997
- T-Cell Subsets Required for Intravesical BCG Immunotherapy for Bladder CancerJournal of Urology, 1993
- Bladder carcinoma as a systemic diseaseCancer, 1979
- An approach for the treatment of penile carcinomaCancer, 1977
- The Concept of Immunological Surveillance1970